We are live on ! Find out more
IONS icon

Ionis Pharmaceuticals
IONS

173 hedge funds and large institutions have $2.84B invested in Ionis Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 173 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more call options, than puts

Call options by funds: $36M | Put options by funds: $29.5M

Holders
173
Holders Change
+173
Holders Change %
–
% of All Funds
5.65%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
173
Increased
–
Reduced
–
Closed
–
Calls
$36M
Puts
$29.5M
Net Calls
+$6.51M
Net Calls Change
+$6.51M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TD Asset Management
76
TD Asset Management
Ontario, Canada
$1.94M +$1.53M +72,000 New
PCM
77
Perkins Capital Management
Minnesota
$1.79M +$1.42M +66,750 New
VOYA Investment Management
78
VOYA Investment Management
Georgia
$1.74M +$1.37M +64,658 New
SONJCPFA
79
State of New Jersey Common Pension Fund A
New Jersey
$1.61M +$1.28M +60,000 New
Comerica Bank
80
Comerica Bank
Texas
$1.57M +$1.24M +58,541 New
Wellington Management Group
81
Wellington Management Group
Massachusetts
$1.57M +$1.24M +58,400 New
PA
82
Profund Advisors
Maryland
$1.52M +$1.2M +56,437 New
T
83
TradeWorx
New Jersey
$1.5M +$1.18M +55,722 New
PPA
84
Parametric Portfolio Associates
Washington
$1.45M +$1.14M +53,779 New
USAA
85
United Services Automobile Association
Texas
$1.41M +$1.12M +52,500 New
U
86
UBS
Switzerland
$1.41M +$1.11M +52,420 New
PP
87
PDT Partners
New York
$1.39M +$1.1M +51,856 New
Connor, Clark & Lunn Investment Management (CC&L)
88
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.33M +$1M +47,085 New
UBS AM
89
UBS AM
Illinois
$1.33M +$1.05M +49,497 New
AQR Capital Management
90
AQR Capital Management
Connecticut
$1.23M +$971K +45,672 New
FSA
91
Franklin Street Advisors
North Carolina
$1.21M +$959K +45,112 New
NIP
92
Nicholas Investment Partners
California
$1.19M +$940K +44,195 New
Natixis Advisors
93
Natixis Advisors
Massachusetts
$1.15M +$907K +42,646 New
Group One Trading
94
Group One Trading
Illinois
$1.13M +$890K +41,854 New
Principal Financial Group
95
Principal Financial Group
Iowa
$1M +$793K +37,302 New
PCMI
96
Princeton Capital Management Inc
New Jersey
$1M +$791K +37,200 New
HT
97
HAP Trading
New York
$996K +$788K +37,076 New
Barclays
98
Barclays
United Kingdom
$931K +$737K +34,672 New
KCG
99
Knight Capital Group
$924K +$731K +34,396 New
PAM
100
Paradigm Asset Management
New York
$918K +$726K +34,150 New
2 3
4
5 6

IONS Hedge Fund Activity: Q2 2013 in Review

173 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q2 2013, worth a combined $2.84B.

Buyers outnumbered sellers: 173 funds opened new IONS positions and 0 closed out — a net gain of 173 holders — while 0 added to existing stakes and 0 trimmed.

  • 173 institutional investors held Ionis Pharmaceuticals (IONS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.84B of Ionis Pharmaceuticals stock for Q2 2013.
  • 173 funds opened new Ionis Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +173 holders.

Based on aggregated 13F filings for Q2 2013.